Disinfection: Is it time to reconsider Spaulding?

Journal of Hospital Infection

Volumn 78, Issue 3, 2011, Pages 163-170

  McDonnell, G ^a   Burke, P ^b  

^a STERIS Limited   (United Kingdom)

^b STERIS Corporation   (United States)

Author keywords

Devices; Disinfection; Resistance; Spaulding; Sterilization

Indexed keywords

BIOCIDE; GLUTARALDEHYDE;

ANTIBIOTIC RESISTANCE; BACTERIUM; DISINFECTION; INSTRUMENT STERILIZATION; MICROBIOLOGY; MICROORGANISM; NONHUMAN; PRION; PROTOZOON; REVIEW; VIRUS; VIRUS RESISTANCE;

CROSS INFECTION; DISINFECTION; DRUG RESISTANCE; ENVIRONMENTAL MICROBIOLOGY; EQUIPMENT AND SUPPLIES; HUMANS; STERILIZATION;

EID: 79958725386     PISSN: 01956701     EISSN: 15322939     Source Type: Journal    
DOI: 10.1016/j.jhin.2011.05.002     Document Type: Review

References (70)

1. McDonnell G. Antisepsis, disinfection and sterilization: types, action and resistance 2007, ASM Press, Washington, DC.
2. Spaulding E.H. Chemical disinfection and antisepsis in the hospital. J Hosp Res 1957, 9:5-31.
3. Song S., Itawi E.A., Saber A.A. Natural orifice translumenal endoscopic surgery (NOTES). J Invest Surg 2009, 22:214-217.
4. Antonnucci T.A., Williams N., Robinson N.A. Reprocessing flexible endoscopes: origin or standards, overview of structure/function, and review of recent outbreaks. Disinfection and decontamination: principles, applications and related issues 2008, 177-214. CRC Press, Boca Raton, FL. G. Manivannann (Ed.).
5. Beguma M., Hocking A.D., Miskelly D. Inactivation of food spoilage fungi by ultra violet (UVC) irradiation. Int J Food Microbiol 2009, 129:74-77.
6. van Klingeren B., Pullen W. Glutaraldehyde resistant mycobacteria from endoscope washers. J Hosp Infect 1993, 25:147-149.
7. Prince H.N., Prince D.L. Principles of viral control and transmission. Disinfection, sterilization and preservation 2000, 543-572. Lippencott Williams & Wilkins, Philadelphia, PA.
8. Sauerbrei A., Wutzler P. Testing thermal resistance of viruses. Arch Virol 2009, 154:115-119.
9. Eterpi M., McDonnell G., Thomas V. Disinfection efficacy against parvoviruses compared with reference viruses. J Hosp Infect 2009, 73:64-70.
10. Bigliardi L., Sansebastiano G. Study on inactivation kinetics of hepatitis A virus and enteroviruses with peracetic acid and chlorine. New ICC/PCR method to assess disinfection effectiveness. J Prev Med Hyg 2006, 47:56-63.
11. Brown K.E. The expanding range of parvoviruses which infect humans. Rev Med Virol 2010, 20:231-244.
12. Durigon G.S., Oliveira D.B.L., Vollet S.B., et al. Hospital-acquired human bocavirus in infants. J Hosp Infect 2010, 76:171-173.
13. Jones M.S., Kapoor A., Lukashov V.V., et al. New DNA viruses identified in patients with acute viral infection syndrome. J Virol 2005, 79:8230-8236.
14. Fryer J.F., Delwart E., Hecht F.M., et al. Frequent detection of the parvoviruses, PARV4 and PARV5, in plasma from blood donors and symptomatic individuals. Transfusion 2007, 47:1054-1061.
15. Corcioli F., Zakrzewska K., Fanci R., et al. Human parvovirus PARV4 DNA in tissues from adult individuals: a comparison with human parvovirus B19 (B19V). Virol J 2010, 7:272.
16. Mahnel H. Variations in resistance of viruses from different groups to chemico-physical decontamination methods. Infection 1979, 7:240-246.
17. Bräuniger S., Fischer I., Peters J. The temperature stability of bovine parvovirus. Zentralbl Hyg Umweltmed 1994, 196:270-278.
18. Terpstra F.G., van den Blink A.E., Bos L.M., et al. Resistance of surface-dried virus to common disinfection procedures. J Hosp Infect 2007, 66:332-338.
19. Eterpi M., McDonnell G., Thomas V. Virucidal activity of disinfectants against parvoviruses and reference viruses. Appl Biosaf 2010, 15:165-171.
20. Mani B., Gerber M., Lieby P., Boschetti N., Kempf C., Ros C. Molecular mechanism underlying B19 virus inactivation and comparison to other parvoviruses. Transfusion 2007, 47:1765-1774.
21. Cromeans T.L., Kahler A.M., Hill V.R. Inactivation of adenoviruses, enteroviruses, and murine norovirus in water by free chlorine and monochloramine. Appl Environ Microbiol 2010, 76:1028-1033.
22. Kahler A.M., Cromeans T.L., Roberts J.M., Hill V.R. Source water quality effects on monochloramine inactivation of adenovirus, coxsackievirus, echovirus, and murine norovirus. Water Res 2011, 45:1745-1751.
23. Meyer B., Cookson B. Does microbial resistance or adaptation to biocides create a hazard in infection prevention and control?. J Hosp Infect 2010, 76:200-205.
24. Chia J.K., Chia A.Y. Chronic fatigue syndrome is associated with chronic enterovirus infection of the stomach. J Clin Pathol 2008, 61:43-48.
25. Ooi M.H., Wong S.C., Lewthwaite P., et al. Clinical features, diagnosis, and management of enterovirus 71. Lancet Neurol 2010, 9:1097-1105.
26. Yilmaz A., Kaleta E.F. Evaluation of virucidal activity of three commercial disinfectants and formic acid using bovine enterovirus type 1 (ECBO virus), mammalian orthoreovirus type 1 and bovine adenovirus type 1. Vet J 2003, 166:67-78.
27. Abad F.X., Pintó R.M., Bosch A. Disinfection of human enteric viruses on fomites. FEMS Microbiol Lett 1997, 156:107-111.
28. Weber D.J., Rutala W.A., Miller M.B., et al. Role of hospital surfaces in the transmission of emerging health care-associated pathogens: norovirus, Clostridium difficile, and Acinetobacter species. Am J Infect Control 2010, 38:S25-S33.
29. Dettenkofer M., Block C. Hospital disinfection: efficacy and safety issues. Curr Opin Infect Dis 2005, 18:320-325.
30. Atmar R.L., Opekun A.R., Gilger M.A., et al. Norwalk virus shedding after experimental human infection. Emerg Infect Dis 2008, 14:1553-1557.
31. Jimenez L., Chiang M. Virucidal activity of a quaternary ammonium compound disinfectant against feline calicivirus: a surrogate for norovirus. Am J Infect Control 2006, 34:269-273.
32. Whitehead K., McCue K.A. Virucidal efficacy of disinfectant actives against feline calicivirus, a surrogate for norovirus, in a short contact time. Am J Infect Control 2010, 38:26-30.
33. Kitajima M., Tohya Y., Matsubara K., et al. Chlorine inactivation of human norovirus, murine norovirus and poliovirus in drinking water. Lett Appl Microbiol 2010, 51:119-121.
34. Gerba C.P., Gramos D.M., Nwachuku N. Comparative inactivation of enteroviruses and adenovirus 2 by UV light. Appl Environ Microbiol 2002, 68:5167-5169.
35. Zoni R., Zanelli R., Riboldi E., et al. Investigation on virucidal activity of chlorine dioxide. Experimental data on feline calicivirus, HAV and coxsackie B5. J Prev Med Hyg 2007, 48:91-95.
36. Cookson B.D., Bolton M.C., Platt J.H. Chlorhexidine resistance in methicillin-resistant Staphylococcus aureus or just an elevated MIC? An in vitro and in vivo assessment. Antimicrob Agents Chemother 1991, 35:1997-2002.
37. McMurry L.M., Oethinger M., Levy S.B. Triclosan targets lipid synthesis. Nature 1998, 394:531-532.
38. Sidhu M.S., Heir E., Leegaard T., et al. Frequency of disinfectant resistance genes and genetic linkage with beta-lactamase transposon Tn552 among clinical staphylococci. Antimicrob Agents Chemother 2002, 46:2797-2803.
39. McDonnell G., Pretzer D. Action and targets of triclosan. ASM News 1998, 64:670-671.
40. Maillard J.Y. Bacterial resistance to biocides in the healthcare environment: should it be of genuine concern?. J Hosp Infect 2007, 65(Suppl. 2):60-72.
41. Griffiths P.A., Babb J.R., Bradley C.R., Fraise A.P. Glutaraldehyde resistant Mycobacterium chelonae from endoscope washer disinfectors. J Appl Microbiol 1997, 82:519-526.
42. Nomura K., Ogawa M., Miyamoto H., et al. Antibiotic susceptibility of glutaraldehyde-tolerant Mycobacterium chelonae from bronchoscope washing machines. Am J Infect Control 2004, 32:185-188.
43. Duarte R.S., Lourenço M.C., Fonseca Lde S., et al. Epidemic of postsurgical infections caused by Mycobacterium massiliense. J Clin Microbiol 2009, 47:2149-2155.
44. Guideline for disinfection and sterilization in healthcare facilities 2008, Healthcare Infection Control Practices Advisory Committee, US CDC, Atlanta, GA.
45. Rodrigues C., Mehta A., Jha U., et al. Nosocomial Mycobacterium chelonae infection in laparoscopic surgery. Infect Control Hosp Epidemiol 2001, 22:474-475.
46. Vijayaraghavan R., Chandrashekhar R., Sujatha Y., Belagavi C.S. Hospital outbreak of atypical mycobacterial infection of port sites after laparoscopic surgery. J Hosp Infect 2006, 64:344-347.
47. van Ingen J., de Zwaan R., Dekhuijzen R.P.N., et al. Clinical relevance of Mycobacterium chelonae-abscessus group isolation in 95 patients. J Infect 2009, 59:324-331.
48. Moore J.E., Kruijshaar M.E., Ormerod L.P., et al. Increasing reports of non-tuberculous mycobacteria in England, Wales and Northern Ireland, 1995-2006. BMC Public Health 2010, 10:612.
49. Svetlíková Z., Skovierová H., Niederweis M., et al. Role of porins in the susceptibility of Mycobacterium smegmatis and Mycobacterium chelonae to aldehyde-based disinfectants and drugs. Antimicrob Agents Chemother 2009, 53:4015-4018.
50. Niederweis M. Mycobacterial porins - new channel proteins in unique outer membranes. Mol Microbiol 2003, 49:1167-1177.
51. McDonnell G. Glutaraldhyde and other aldehyde resistant bacteria associated with the use of washer disinfectors March 2009, Society for Healthcare Epidemiology of America (SHEA) 19th Annual Scientific Meeting, San Diego, CA, USA, 19-22.
52. Thomas V., McDonnell G., Denyer S.P., Maillard J.Y. Free-living amoebae and their intracellular pathogenic microorganisms: risks for water quality. FEMS Microbiol Rev 2009, 34:231-259.
53. Coulon C., Collignon A., McDonnell G., Thomas V. Resistance of Acanthamoeba cysts to disinfection treatments used in health care settings. J Clin Microbiol 2010, 48:2689-2697.
54. Greub G., Raoult D. Biocides currently used for bronchoscope decontamination are poorly effective against free-living amoebae. Infect Control Hosp Epidemiol 2003, 24:784-786.
55. Thomas V., McDonnell G. Efficacy of hydrogen peroxide gas against amoebal cysts and amoebae-associated mycobacteria June 2008, Poster, ASM Annual General Meeting, Boston, MA, USA, 1-6.
56. Barbee S.L., Weber D.J., Sobsey M.D., Rutala W.A. Inactivation of Cryptosporidium parvum oocyst infectivity by disinfection and sterilization processes. Gastrointest Endosc 1999, 49:605-611.
57. Sell J.M., Haire D., Antloga K., et al. Efficacy of peracetic acid against Cryptosporidium and Giardia 20-24 May 2001, Poster, ASM Annual General Meeting, Orlando, FL, USA.
58. Khan N.A., Siddiqui R., Elsheikha H. Enemy within: strategies to kill 'superbugs' in hospitals. Int J Antimicrob Agents 2010, 36:288-294.
59. Janda W.M. Amoeba-resistant bacteria: their role in human infections. Clin Microbiol Newslett 2010, 32:177-184.
60. Taylor D.M. Inactivation of transmissible degenerative encephalopathy agents; a review. Vet J 2000, 159:10-17.
61. McDonnell G. Prion disease transmission: can we apply standard precautions to prevent or reduce risks?. J Perioper Pract 2008, 18:298-304.
62. Infection control guidelines for transmissible spongiform encephalopathies 2000. Report of a WHO consultation 1999, World Health Organization, WHO/CDS/CSR/APH/2000/3, WHO, Geneva.
63. Fichet G., Harrison J., McDonnell G. Reduction of risk of prion transmission on surgical devices with effective cleaning processes. Centr Sterilis 2007, 15:418-437.
64. Fichet G., Antloga K., Comoy E., et al. Prion inactivation using a new gaseous hydrogen peroxide sterilisation process. J Hosp Infect 2007, 67:278-286.
65. Rogez-Kreuz C., Yousfi R., Soufflet C., et al. Inactivation of animal and human prions by hydrogen peroxide gas plasma sterilization. Infect Control Hosp Epidemiol 2007, 30:769-777.
66. Yan Z.X., Stitz L., Heeg P., et al. Infectivity of prion protein bound to stainless steel wires: a model for testing decontamination procedures for transmissible spongiform encephalopathies. Infect Control Hosp Epidemiol 2004, 25:280-283.
67. Aguzzi A. Cell biology: beyond the prion principle. Nature 2009, 459:924-925.
68. Scheibel T., Buchner J. Protein aggregation as a cause for disease. Handb Exp Pharmacol 2006, 172:199-219.
69. Meyer-Luehmann J., Coomaraswamy T., Bolmont S., et al. Exogenous induction of cerebral amyloidogenesis is governed by agent and host. Science 2008, 313:1781-1784.
70. Eisele Y.S., Bolmont T., Heikenwalder M., et al. Induction of cerebral beta-amyloidosis: intracerebral versus systemic Abeta inoculation. PNAS USA 2009, 106:12926-12931.